Assembly Biosciences, Inc. (ASMB) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Assembly Biosciences, Inc. (ASMB) closed at USD 20.53 on 2026-10-14, a change of -33.5 % over the past year, with a market capitalization of USD 418.82M.

Assembly Biosciences, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Assembly Biosciences, Inc. key figures

Previous close

USD 20.53 (2026-10-14)

1-year change

-33.5 %

Market cap

USD 418.82M

Enterprise value

USD 100.81M

P/E ratio (trailing)

19.59

P/E ratio (forward)

-7.99

EPS (trailing)

1.05

EPS (forward)

-2.57

PEG ratio

n/a

Price to book

1.34

Revenue growth

38.9 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

7.57

Employees

73

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Assembly Biosciences, Inc.

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5366 and ABI-1179, which are in Phase 1 clinical studies for recurrent genital herpes; and ABI-6250, an orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical study for the treatment of chronic hepatitis delta virus (HDV) infection. The company also develops ABI-4334, an orally bioavailable next generation capsid assembly modulator that is in Phase 1b study clinical trial for the treatment of chronic hepatitis B virus (HBV) infection; and ABI-7272, an oral broad-spectrum NNPI for the treatment of transplant-associated herpesviruses. It has an option, license, and collaboration agreement with Gilead Sciences, Inc. for the research and development of virology therapies. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Assembly Biosciences, Inc. and compare it with other stocks.